SNAP Trial

SNAP Trial Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from SNAP Trial, Medical and health, 792 Elizabeth Street, Melbourne.

The Staphylococcus aureus bacteraemia Network Adaptive Platform Trial is an innovative trial to evaluate a range of interventions with the aim of improving outcomes for patients with Staphylococcus aureus bacteraemia (AKA bloodstream infections).

🎉 Celebrating a Milestone for the SNAP Consumer Reference Group! 🎉We’re proud to share that the SNAP Trial Consumer Refe...
15/08/2025

🎉 Celebrating a Milestone for the SNAP Consumer Reference Group! 🎉

We’re proud to share that the SNAP Trial Consumer Reference Group has been recognised as Judge’s Choice Runner-Up in the Outstanding Consumer Advisory Group Impact on Health and Medical Research category at the Australian Consumer Partnerships in Research 2025 Awards. 🏆

This award acknowledges the incredible work of our Consumer Reference Group members, who share their lived experiences of Staphylococcus aureus bloodstream infection and sepsis to ensure our global trial is shaped by the voices of patients and families. Their insights guide SNAP’s research priorities, improve accessibility, and help us communicate findings in ways that truly resonate with the community.

A heartfelt thank you to our CRG members, researchers, and supporters across the SNAP network. This recognition is yours. 💙

We’re thrilled to share that the SNAP Trial Consumer Reference Group has been named a Finalist in the 2025 Australian Co...
25/07/2025

We’re thrilled to share that the SNAP Trial Consumer Reference Group has been named a Finalist in the 2025 Australian Consumer Partnerships in Research Awards!

We're proud to be recognised in Category F: Outstanding Consumer Advisory Group Impact on Health and Medical Research. From trial design and governance to inclusive communication and long-term outcomes - this group continues to amplify the voices of those with lived experience.

Thank you to our Consumer Reference Group members for shaping SNAP every step of the way.

What’s SNAP-pening in 2025?
10/07/2025

What’s SNAP-pening in 2025?

A huge thank you to our incredible research staff and participants who participated in this survey! Your feedback will h...
15/06/2025

A huge thank you to our incredible research staff and participants who participated in this survey! Your feedback will help make research more engaging and accessible for everyone. 🙌

Being an adaptive clinical trial, SNAP has the opportunity to continuously implement new and innovative ideas to study. ...
03/06/2025

Being an adaptive clinical trial, SNAP has the opportunity to continuously implement new and innovative ideas to study. Investigators behind the scenes are always on the lookout for the next big research question that we want to answer for Staphylococcus aureus bacteremia. Here are some ideas that are in different stages of implementation in the SNAP Trial!

Happy International Nurses Day!Today, we take time to celebrate nurses all over the world, including research nurses who...
12/05/2025

Happy International Nurses Day!

Today, we take time to celebrate nurses all over the world, including research nurses who work on studies such as SNAP.
Research studies could not happen without the knowledge, kindness, organisation, and hard work of research nurses and coordinators.
We are so grateful for everything you do for patients and for research! Thank you!

This Paediatric Sepsis Week (April 20–26), we’re highlighting the importance of recognising sepsis in children—and how r...
16/04/2025

This Paediatric Sepsis Week (April 20–26), we’re highlighting the importance of recognising sepsis in children—and how research like the SNAP Trial is working to improve treatment.

Sepsis can escalate quickly, especially in children. Knowing the signs can save lives. If you suspect sepsis, seek urgent care and ask, “could it be sepsis?”

Research plays a crucial role in improving how we treat serious infections like 𝘚𝘵𝘢𝘱𝘩𝘺𝘭𝘰𝘤𝘤𝘶𝘴 𝘢𝘶𝘳𝘦𝘶𝘴 bloodstream infections (SAB)—a common cause of sepsis. The SNAP Trial is a global study designed to find better treatments for SAB across all ages, including children. Our Consumer Reference Group, made up of people with lived experience of sepsis, has championed the importance of including children in research—because every child involved helps us get closer to evidence-based care.

Thank you for helping spread awareness and supporting research that could make a difference for kids and families everywhere.

To learn more about sepsis in children, visit the Sepsis Alliance: sepsis.org/pediatric-sepsis-week, Sepsis Australia https://www.australiansepsisnetwork.net.au/ or https://pch.health.wa.gov.au/For-patients-and-visitors/Sepsis

When research listens to those who’ve lived it, we all benefit.Lyn Whiteway shares how the SNAP Consumer Reference Group...
07/04/2025

When research listens to those who’ve lived it, we all benefit.

Lyn Whiteway shares how the SNAP Consumer Reference Group is making Staph aureus research stronger and more patient-focused.

Read more below.

SNAP Trial: Breaking New Ground in Staph Aureus Research! 🔬 Milestone Alert: We've surpassed 4,000 participants in our q...
10/02/2025

SNAP Trial: Breaking New Ground in Staph Aureus Research!
🔬 Milestone Alert: We've surpassed 4,000 participants in our quest to find the most effective treatment for Staph. aureus bloodstream infections!
📊 Data Dive: Our 8th interim analysis is coming up, examining data from these 4,000 heroes. This could lead to groundbreaking insights and potential publications, while we continue our mission.
🌍 Global Growth: 128 hospitals across 8 regions are now part of the SNAP family, with more countries and hospitals joining soon. Each new site brings us closer to cracking the Staph. aureus code!
🙏 Your support fuels our progress. Stay tuned as we continue our efforts to advance our knowledge of Staph. aureus bloodstream infections.

Thank you for following the SNAP Trial this year! 🎉On behalf of the entire SNAP Team, we wish you a Merry Christmas and ...
19/12/2024

Thank you for following the SNAP Trial this year! 🎉

On behalf of the entire SNAP Team, we wish you a Merry Christmas and a Joyful New Year! As we reflect on the past year, we are grateful for your support and engagement. We look forward to sharing more exciting updates with you in the coming year.

Stay tuned for more adventures ahead! 🌟

SNAP Trial: Breaking New Ground in Staph Aureus Research! 🔬 Milestone Alert: We've surpassed 3,500 participants in our q...
12/12/2024

SNAP Trial: Breaking New Ground in Staph Aureus Research!
🔬 Milestone Alert: We've surpassed 3,500 participants in our quest to find the most effective treatment for Staph. aureus bloodstream infections!
📊 Data Dive: Our 7th analysis is coming up, examining data from these 3,500 heroes. This could lead to groundbreaking insights and potential publications, while we continue our mission.
🌍 Global Growth: 125 hospitals across 8 regions are now part of the SNAP family, with more countries and hospitals joining soon. Each new site brings us closer to cracking the Staph. aureus code!
🙏 Your support fuels our progress. Stay tuned as we continue our efforts to advance our knowledge of Staph. aureus bloodstream infections.

SNAP Presented at the 19th International Symposium for Staphylococci and Staphylococcal Infections (ISSSI)The SNAP Trial...
12/12/2024

SNAP Presented at the 19th International Symposium for Staphylococci and Staphylococcal Infections (ISSSI)

The SNAP Trial was well represented at the Perth-hosted ISSSI conference in September, with delegates from The Kids Research Institute Australia and The Peter Doherty Institute presenting on multiple aspects of SNAP. Presentations included:
• A Cultural Governance poster presented by Gillian Woods (Community Project Coordinator)
• Professor Asha Bowen (SNAP-PY Lead) presented on paediatric aspects of the trial
• Keerthi Anpalagan (PhD candidate) presented on a SNAP sub study called SNOOPY looking at the feasibility of whole body doppler ultrasounds to detect clots in SNAP participants
• Caitlin Symons (SNAP-PY Trial Officer) presented on consumer aspects of the trial
• Chief Investigator Steve Tong rounded things off with a presentation on past and current clinical trials for Staph. aureus Bloodstream infections.

Address

792 Elizabeth Street
Melbourne, VIC
3000

Alerts

Be the first to know and let us send you an email when SNAP Trial posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Featured

Share